The trajectory of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical arena . Despite its initial success and generation of vast in sales, the intellectual property lapse has opened the door for competing medications, greatly reducing profit potential . This shift raises questions ab